TR
EN
Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al.
Abstract
Abstract is not required for letter to editor.
Abstract is not required for letter to editor.
Keywords
References
- 1. Erkut M, Ozkaya E, Fidan S, Cosar AM. Fecal Calprotectin at the Time of Diagnosis May Indicate the Presence of Complications in Inflammatory Bowel Disease. J Contemp Med. 2024;14(1):1-8. 2. Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99:1051-62. 3. Goldstone RN, Steinhagen RM. Abdominal emergencies in inflammatory bowel disease. Surg Clin North Am.2019;99:1141-50. 4. Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci. 2019;56:307-20. 5. Sipponen T, Kolho KL. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:74-80.
Details
Primary Language
English
Subjects
Gastroenterology and Hepatology
Journal Section
Letter to Editor
Authors
Early Pub Date
May 24, 2025
Publication Date
May 31, 2025
Submission Date
November 10, 2024
Acceptance Date
April 28, 2025
Published in Issue
Year 2025 Volume: 15 Number: 3
APA
Başpınar, B., & Güven, İ. E. (2025). Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. Journal of Contemporary Medicine, 15(3), 144-145. https://doi.org/10.16899/jcm.1582362
AMA
1.Başpınar B, Güven İE. Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. J Contemp Med. 2025;15(3):144-145. doi:10.16899/jcm.1582362
Chicago
Başpınar, Batuhan, and İbrahim Ethem Güven. 2025. “Fecal Calprotectin As a Predictor of Complications in IBD: A Commentary on the Article by Erkut et Al”. Journal of Contemporary Medicine 15 (3): 144-45. https://doi.org/10.16899/jcm.1582362.
EndNote
Başpınar B, Güven İE (May 1, 2025) Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. Journal of Contemporary Medicine 15 3 144–145.
IEEE
[1]B. Başpınar and İ. E. Güven, “Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al”., J Contemp Med, vol. 15, no. 3, pp. 144–145, May 2025, doi: 10.16899/jcm.1582362.
ISNAD
Başpınar, Batuhan - Güven, İbrahim Ethem. “Fecal Calprotectin As a Predictor of Complications in IBD: A Commentary on the Article by Erkut et Al”. Journal of Contemporary Medicine 15/3 (May 1, 2025): 144-145. https://doi.org/10.16899/jcm.1582362.
JAMA
1.Başpınar B, Güven İE. Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. J Contemp Med. 2025;15:144–145.
MLA
Başpınar, Batuhan, and İbrahim Ethem Güven. “Fecal Calprotectin As a Predictor of Complications in IBD: A Commentary on the Article by Erkut et Al”. Journal of Contemporary Medicine, vol. 15, no. 3, May 2025, pp. 144-5, doi:10.16899/jcm.1582362.
Vancouver
1.Batuhan Başpınar, İbrahim Ethem Güven. Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. J Contemp Med. 2025 May 1;15(3):144-5. doi:10.16899/jcm.1582362